The goal of our project is to engineer the commensal gut bacterium Pseudomonas alcaligenes to autonomously produce and secrete therapeutic molecules inside the zebrafish gut. We use Danio rerio (zebrafish) larvae as our model organism, whose optical transparency and conserved gut physiology enable live imaging of colonization of our engineered bacteria. We first validate our delivery strategy using fluorescent proteins, before advancing to the microbial synthesis of L-DOPA, the main treatment for Parkinson's disease. We aim to validate our production of L-DOPA in vitro, and with HPLC, before introducing the bacteria into the zebrafish. Moreover, considerations of biosafety are also implemented in the wet lab activities of our project by the design of killswitches. We also test the colonization of our bacteria in a human intestinal transwell model, to bridge the gap between zebrafish proof of concept and a potential application in humans.
Select a section below to view the engineering design cycles for that aspect of our project. Each section contains multiple experiments that follow the Design → Build → Test → Learn cycle.
[Your description of the design process]